New Chapter Magnesium + Aswagandha product packaging

Image: NIH Office of Dietary Supplements, Dietary Supplement Label DatabaseNo separate image reuse license stated

New Chapter

Magnesium + Aswagandha

Tablet or Pill

Serving size1 Tablet(s)
Servings per containerNot listed
Package90 Tablet(s)
Data retrievedJul 28, 2026

Checking your goal…

Checking with your list…

1 labeled serving/day preview
Open the complete check →

Supplement Facts

Serving size 1 Tablet(s)

Magnesium325 mg77% DV
Seawater175 mgDV not established
Magnesium Bisglycinate Chelate; Buffered150 mgDV not established
Sensoril25 mgDV not established

Other ingredients

Gum Acacia; Magnesium Stearate (Mg Stearate); Brown Rice; Hydroxypropyl Cellulose (HPC); Silica; Maltodextrin; Sunflower Lecithin; Palm Oil; Guar Gum

Label directions

Suggested use: Take one tablet daily.

Label warnings

Caution: As with any dietary supplement you should advise your healthcare professional of the use of this product if you have a medical condition or are taking medication. If you are nursing pregnant or considering pregnancy consult your healthcare professional prior to using this product. Do not exceed suggested use. Keep out of reach of children. Discontinue use and contact your healthcare professional if you experience a side effect or an allergic reaction.

Identity and label version

NIH label record326597
Entered into NIH DSLDApr 24, 2025
UPC / GTINNot listed
Manufacturer / distributor on labelNew Chapter Inc.
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.

NIH label history (1)

Current labelNIH record 326597Entered Apr 24, 2025
Serving size1 Tablet(s)
Formula version1d2f51ce
Ingredients on label4
NIH sourceOpen label ↗
Magnesium325 mg
Seawater175 mg
Magnesium Bisglycinate Chelate; Buffered150 mg
Sensoril25 mg

Label warning: Caution: As with any dietary supplement you should advise your healthcare professional of the use of this product if you have a medical condition or are taking medication. If you are nursing pregnant or considering pregnancy consult your healthcare professional prior to using this product. Do not exceed suggested use. Keep out of reach of children. Discontinue use and contact your healthcare professional if you experience a side effect or an allergic reaction.

Sources and traceability

  • NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026
    Open source ↗

More from New Chapter

Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.